{"id":174709,"date":"2026-09-26T18:47:57","date_gmt":"2026-09-26T18:47:57","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/174709\/"},"modified":"2026-09-26T18:47:57","modified_gmt":"2026-09-26T18:47:57","slug":"novo-and-aws-sign-ai-drug-discovery-pact-launch-london-hub","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/174709\/","title":{"rendered":"Novo and AWS sign AI drug discovery pact, launch London hub"},"content":{"rendered":"<p>Novo Nordisk and Amazon Web Services (AWS) will partner to leverage AI and accelerate drug discovery.<\/p>\n<p>The deal will result in AWS becoming Novo\u2019s preferred cloud provider and AI partner, while creating a hub within Big Pharma&#8217;s existing London facility where the two companies will collaborate on how to accelerate the development of new medicines, according to an August 10 release.<\/p>\n<p>Novo Nordisk CEO Mike Doustdar said the collaboration was about \u201cmaking AI a driver of innovation\u201d across the company.<\/p>\n<p>\u201cWe are accelerating discovery and developing responsible AI solutions that will create real progress for people living with serious chronic diseases,\u201d Doustdar added.<\/p>\n<p>The agreement is designed to unite Novo\u2019s therapeutic knowledge across chronic disease with AWS\u2019 cloud and AI services, secure infrastructure and life sciences technologies, according to the release. Novo said the partnership had already resulted in a reduction in clinical documentation time and made 25,000 employees more productive.<\/p>\n<p>As part of the collaboration, Novo will have access to services such as Amazon Bio Discovery, which offers scientists AI models trained on biological datasets, as well as Amazon Bedrock, which is used to build AI apps. The tools are meant to identify drug targets, design new therapies and bring together clinical, genomic and imaging data to create biotech breakthroughs, according to the release.<\/p>\n<p>The Danish Big Pharma will also deploy Amazon Bedrock AgentCore\u2014a managed infrastructure platform to help developers deploy and scale AI agents\u2014in an effort to make its operations more efficient.\u00a0<\/p>\n<p>\u201cEvery part of our work with Novo Nordisk comes back to one thing: getting the right medicine to patients, faster,\u201d AWS CEO Matt Garman said in the release. \u201cWe\u2019re excited to partner with Novo Nordisk so that these technologies, AWS forward-deployed engineers and Novo Nordisk\u2019s industry-leading science teams can help compress drug discovery timelines, securely process complex datasets and scale findings across therapeutic areas.\u201d<\/p>\n<p>The pact is an extension of Novo\u2019s ongoing collaboration with Amazon, which also includes Amazon Pharmacy, Amazon Ads and Amazon One Medical throughout its business functions. AWS put this morning&#8217;s announcement in the context of AWS\u2019 <a href=\"https:\/\/url.us.m.mimecastprotect.com\/s\/i4tPCpYlnPfvO313iPf2NhGRBq0?domain=aboutamazon.com\" rel=\"nofollow noopener\" target=\"_blank\">recently launched<\/a> Forward Deployed Engineering organization, where experts are embedded with AWS customers to co-develop and design agentic AI throughout the client\u2019s business.<\/p>\n<p>Among the numerous AI drug discovery collaborations that have been signed in 2026, AWS has also announced AI partnerships with biotech company creator <a href=\"https:\/\/www.prnewswire.com\/news-releases\/flagship-pioneering-and-aws-announce-collaboration-to-accelerate-drug-discovery-and-life-sciences-innovation-302730748.html\" rel=\"nofollow noopener\" target=\"_blank\">Flagship Pioneering<\/a> to accelerate drug discovery and with <a href=\"https:\/\/www.fiercebiotech.com\/medtech\/jj-launches-ai-surgery-funding-competition-nvidia-aws\" rel=\"nofollow noopener\" target=\"_blank\">Johnson &amp; Johnson<\/a> to bring AI into the operating room.<\/p>\n<p>Novo&#8217;s own AI explorations have seen the Copenhagen-headquartered pharma work with ChatGPT parent company <a href=\"https:\/\/www.fiercepharma.com\/pharma\/novo-taps-openai-deploy-ai-across-rd-manufacturing-and-corporate-functions\" rel=\"nofollow noopener\" target=\"_blank\">OpenAI<\/a> to integrate AI \u201cglobally from discovery to commercial operations.\u201d The company has also <a href=\"https:\/\/www.fiercebiotech.com\/biotech\/opportunities-are-immense-novo-nordisk-signs-use-danish-supercomputer\" target=\"_blank\" rel=\"nofollow noopener\">signed up as a customer<\/a> of Denmark\u2019s first so-called \u201csupercomputer.\u201d<\/p>\n<p>\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"Novo Nordisk and Amazon Web Services (AWS) will partner to leverage AI and accelerate drug discovery. The deal&hellip;\n","protected":false},"author":2,"featured_media":174710,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[80287,3759,1204,15043,20945,16749,53460,272],"class_list":["post-174709","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-ai-and-machine-learning","tag-amazon-web-services","tag-artificial-intelligence","tag-biotech","tag-deals","tag-drug-discovery","tag-fierce-biotech-homepage","tag-novo-nordisk"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/117338839738010150","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/174709","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=174709"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/174709\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/174710"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=174709"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=174709"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=174709"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}